Concepedia

Kunal Saxena

KS

Statistics

Publications

18

Citations

545

H-Index

15

Active since

2012

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Virginia Commonwealth University

University of Bristol

Chinese University of Hong Kong

Analysis Group (United States)

Kunal Saxena is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in immunization, vaccinology, and vaccination.

Publications per year

2012–2024

18

Publications

18

Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis

Vincent Daniels, Kunal Saxena, Craig S. Roberts et al. · Vaccine · 2021 · 108 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +17

Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States

Kunal Saxena, Jessica R. Marden, Cristina Carias et al. · Current Medical Research and Opinion · 2021 · 69 citations

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Identification of phosphorylation sites in the <scp>COOH</scp>‐terminal tail of the μ‐opioid receptor

Ying‐Ju Chen, S. Oldfield, Adrian J. Butcher et al. · Journal of Neurochemistry · 2012 · 43 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Impact of Appointment-Based Medication Synchronization on Existing Users of Chronic Medications

David A. Holdford, Kunal Saxena · Journal of Managed Care & Specialty Pharmacy · 2015 · 43 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacy Practice +12

HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US

Kunal Saxena, Niranjan Kathe, Poorva Sardana et al. · Human Vaccines & Immunotherapeutics · 2023 · 39 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

1–5 of 18